Deal Announcement Labquality

Type of deal/project: Acquisition of shares (majority)

Sector: Quality and consulting services to healthcare, pharmaceutical and medical technology sectors

PwC Finland had the pleasure of advising Cor Group in their divestment of a controlling stake in Labquality to Mérieux Equity Partners.

Labquality specialises in quality services for the healthcare, pharmaceutical, and medical technology sectors. Its offering includes external quality assessments, regulatory consulting, clinical investigations and trials, audits and certifications, as well as training services. The transaction allows Labquality to advance its buy-and-build strategy in Europe with support from Mérieux Equity Partners' industry knowledge and financial backing.

PwC provided financial and tax vendor due diligence for the transaction.

Seller: Cor Group Oy

Buyer: Mérieux Equity Partners

Deal announcement date: 30 November 2023

PwC's role: Financial and tax advisor

Press release